Form 4: BioLife Solutions Director Acquires 8,170 Shares

Amy DuRoss, a Director at BioLife Solutions Inc., acquired 8,170 shares of common stock through a restricted stock grant.

Summary

• Amy DuRoss, a Director of BioLife Solutions Inc. (BLFS), acquired 8,170 shares of the company's common stock.
• The transaction occurred on February 24, 2026.
• The acquisition was a direct ownership of restricted stock.
• Following this transaction, Amy DuRoss beneficially owns 26,857 shares of common stock.
• The restricted stock was granted under the BioLife Solutions 2023 Performance Incentive Plan.
• The granted shares will fully vest on the first anniversary of the vesting date, which is January 2, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive event, as a director's acquisition of shares, even through a grant, generally signals confidence in the company's future, though it is a routine compensation disclosure.

Positives

• A Director's acquisition of shares, even through a grant, can signal confidence in the company's future prospects.
• The grant is part of a performance incentive plan, aligning management's interests with shareholder value.

Future Outlook

The filing indicates a future vesting event for the restricted stock on the first anniversary of January 2, 2026, aligning director incentives with long-term performance.

Industry Context

StockSavvy.ai notes that restricted stock grants are a common form of executive and director compensation in the biotechnology and life sciences industry, aiming to retain talent and align their interests with long-term company performance. This grant to a director is a standard practice within corporate governance frameworks.

Comparison to Industry Standards

• Restricted stock grants are a standard component of executive and director compensation packages across various industries, including life sciences, comparable to practices at companies like Thermo Fisher Scientific or Danaher Corporation, which utilize similar equity incentive plans to motivate and retain key personnel.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant aligns the director's financial interests with the company's long-term performance, potentially benefiting shareholders if the company performs well.
• Employees: The use of an incentive plan suggests a structured approach to compensation that could extend to other key personnel, fostering a performance-driven culture.

Next Steps

• The restricted stock will fully vest on the first anniversary of January 2, 2026.

Key Dates

Keywords

BioLife Solutions, BLFS, Amy DuRoss, Insider Trading, Form 4, Restricted Stock Grant, Director Share Acquisition, Equity Compensation